Hudson Bay Capital Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,731
Closed -$341K 854
2022
Q4
$341K Buy
+20,731
New +$233K ﹤0.01% 731
2020
Q3
Sell
-780,000
Closed -$8.35M 542
2020
Q2
$8.35M Buy
+780,000
New +$4.29M 0.15% 120
2019
Q2
Sell
-261,806
Closed -$759K 415
2019
Q1
$759K Buy
+261,806
New +$780K 0.01% 582
2018
Q4
Sell
-50,000
Closed -$220K 769
2018
Q3
$220K Buy
50,000
+6,917
+16% +$75.3K ﹤0.01% 659
2018
Q2
$575K Buy
+43,083
New +$848K 0.01% 687
2018
Q1
Sell
-13,619
Closed -$813K 758
2017
Q4
$813K Buy
+13,619
New +$870K 0.02% 410
2017
Q1
Sell
-1,650
Closed -$1.61M 784
2016
Q4
$1.61M Sell
1,650
-3,422
-67% -$3.07M 0.03% 393
2016
Q3
$4.41M Sell
5,072
-3,265
-39% -$2.56M 0.11% 153
2016
Q2
$6.1M Sell
8,337
-2,108
-20% -$1.44M 0.19% 87
2016
Q1
$5.92M Buy
10,445
+2,641
+34% +$1.35M 0.28% 50
2015
Q4
$4.45M Sell
7,804
-2,420
-24% -$1.21M 0.25% 75
2015
Q3
$4.08M Sell
10,224
-2,143
-17% -$1.02M 0.18% 87
2015
Q2
$6.68M Buy
12,367
+4,306
+53% +$2.18M 0.2% 106
2015
Q1
$3.94M Buy
8,061
+7,519
+1,387% +$3.75M 0.1% 115
2014
Q4
$294K Hold
542
0.01% 165
2014
Q3
$289K Buy
+542
New +$283K 0.01% 197

Other funds holding ALT

Hudson Bay Capital Management's ALT Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Altimmune (ALT) in Q1 2023, closing a stake of 20,731 shares — an estimated $341K sold.

Hudson Bay Capital Management first reported a position in ALT in Q3 2014 and held it in 16 quarters. The position peaked at $8.35M in Q2 2020. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.

  • Hudson Bay Capital Management reported no remaining Altimmune position as of Q1 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 20,731 Altimmune shares in Q1 2023, an estimated $341K.
  • Hudson Bay Capital Management first reported a position in Altimmune in Q3 2014 and held it in 16 quarters.
  • Hudson Bay Capital Management's Altimmune position peaked at $8.35M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.